Julie J. Lee

Public Health and Preventive Medicine

300 Pasteur Dr
Stanford, CA 94305

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 23, 2025

Narrative Medicine Workshop on Climate Change for Physicians: A Brief Case on Advocacy Skill-Building.

Narrative Medicine Workshop on Climate Change for Physicians: A Brief Case on Advocacy Skill-Building.

Journal: Journal of general internal medicine

Published: April 24, 2025

Perspectives on Artificial Intelligence-Generated Responses to Patient Messages.

Perspectives on Artificial Intelligence-Generated Responses to Patient Messages.

Journal: JAMA network open

Published: October 16, 2024

Data Transformation to Advance AI/ML Research and Implementation in Primary Care.

Data Transformation to Advance AI/ML Research and Implementation in Primary Care.

Journal: Annals of family medicine

Published: September 19, 2024

Transforming the Primary Care Journey with Generative AI: A Foundation Model to Boost Efficiency, Quality, and Engagement.

Transforming the Primary Care Journey with Generative AI: A Foundation Model to Boost Efficiency, Quality, and Engagement.

Journal: Journal of general internal medicine

Published: August 29, 2024

Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.

Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 15, 2024

CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab.

CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 18, 2024

Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin.

Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin.

Journal: Diabetes care

Published: March 22, 2024

Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism.

Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 21, 2023

Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet.

Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet.

Journal: Neurology

Published: January 25, 2023

Paging the Clinical Informatics Community: Respond STAT to Dobbs v. Jackson's Women's Health Organization.

Paging the Clinical Informatics Community: Respond STAT to Dobbs v. Jackson's Women's Health Organization.

Journal: Applied clinical informatics

Published: December 19, 2022

Rotterdam criteria-based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study.

Rotterdam criteria-based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study.

Journal: Journal of the American Academy of Dermatology

Published: November 21, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026